江苏复旦复华药业

Jiangsu Fudan Fuhua Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the publicly traded Shanghai Fudan Forward S&T Co., Ltd. The company focuses on the development, production, and sales of high-quality chemical drugs, including both active pharmaceutical ingredients (APIs) and finished dosage forms. Its therapeutic focus spans cardiovascular and cerebrovascular diseases, digestive system disorders, and neurology. Key products in its portfolio include Vincamine, Nimodipine, and Glutathione, which are produced in its GMP-certified facilities in Haimen, Jiangsu. The company leverages its historical connection to Fudan University for research and development, aiming to provide innovative and affordable healthcare solutions. It maintains a strong presence in the Chinese domestic market while expanding its international footprint through export-oriented manufacturing.